Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +39.6% | -21.8% | 1 / 3 | +5.1% | +2.52 pp | +0.95 pp | +5.7% | 0.61 | 11.52 | 9.993 | +5,1% | 382 | +39,6% | 11.52 | 11.66 | −1,2% |
| Pts | 8 | 0 | 4 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 10.450 (close price on 2026-10-19)EPS (TTM): 907,1
Financial charts
1.Revenue & growth
VND bn9.993Q2/26
1.Revenue & growth
VND bn9.993Q2/26
2.Profit & growth
VND bn382Q2/26
3.Profit mix (Penman)
VND bn809Q2/26
4.Margins & cost structure
%12.7%Q2/26
5.Returns & cash cycle
% · days4.8%Q2/26
6.Earnings quality & cash
VND bn723Q2/26
7.Asset structure
VND bn22.215Q2/26
8.Funding & debt health
VND bn · times22.215Q2/26
9.Revenue backlog
VND bn271Q2/26
10.Valuation
times · %12,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %473Q2/26
Adjusted EPS growth, latest quarter
39.6%
Average adjusted EPS growth, 3 quarters
-21.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26